CapitalSource completes the sale of 40 long-term care facilities to Omega Health Care Investors

NewsGuard 100/100 Score

CapitalSource Inc. (NYSE: CSE) today announced that it has completed the sale of 40 long-term care facilities to Omega Health Care Investors Inc. (NYSE: OHI), as per the terms of the previously announced Securities Purchase Agreement between the parties.

In this closing, CapitalSource received net proceeds from Omega of $234.8 million, consisting of $184.2 million in cash; and 2,714,959 shares of Omega common stock (valued at $50.6 million under the Purchase Agreement). Additionally, Omega assumed $59.4 million of debt associated with the 40 properties purchased. Included in the purchase price was $25 million for an option which can be exercised by Omega to acquire 63 additional long-term care facilities at any time through December 31, 2011 (step three of the Purchase Agreement). CapitalSource expects step two of the transaction for an additional 40 long-term care facilities to close on or about April 1, 2010.

As previously disclosed, CapitalSource expects to use the proceeds from the Omega sale to add to parent company liquidity and reduce the committed capacity of the Company's syndicated bank facility from the current level of $525 million. The Omega stock received by CapitalSource is required to be registered by Omega in the first quarter of 2010.

SOURCE CapitalSource Inc.

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Lab to plant: Scaling up API processes with Dr. James Mencel's guidance